Back to peptide library

Recovery & tissue support

BPC-157 Injectable

Body Protection Compound support for gut integrity, tissue repair, tendon and ligament recovery, joint support, and comprehensive healing under clinician guidance.

15 amino-acid peptideGut and tissue supportSubQ IPS routeCustom protocol

The science

What is BPC-157 Injectable?

BPC-157, often called Body Protection Compound-157, is a 15-amino-acid peptide derived from a protective protein found naturally in human gastric juice.

IPS frames BPC-157 around gut integrity, connective-tissue support, tendon and ligament recovery, soft-tissue repair, joint support, and post-injury recovery planning.

Injectable BPC-157 is the more targeted BPC option when the primary goals involve tendon, ligament, muscle, joint, wound, or localized soft-tissue recovery.

Ideal for

  • Patients whose goals match this protocol category
  • Recovery plans that require clinician review
  • Patients needing instructions, monitoring, and candidacy screening
  • Plans integrated with rehab, nutrition, sleep, and lifestyle strategy

Available through IPS

Clinical protocol context.

IPS reviews route, timing, candidacy, contraindications, tolerance, and protocol details privately during consultation. Public pages do not list dosing or pricing.

Injectable

BPC-157 Injectable

Reviewed privately during consultation. Public pages do not display dosing or pricing.

Related oral option

BPC-157 Oral Capsules

Gut-focused BPC option when digestive support is the primary goal.

Related blend

BPC-157 + TB-500

Foundation recovery blend for local plus systemic recovery support.

Advanced blend

BPC-157 + TB-500 + KPV + GHK-Cu

Advanced recovery blend. KPV is only shown as a component of this blend.

How it works

Mechanism and clinical use.

This page explains the core mechanisms and clinical focus areas without presenting a self-selection menu.

Angiogenesis support

Supports blood-flow and tissue-repair signaling pathways.

Growth-factor signaling

Supports collagen and tissue-regeneration pathways.

Cellular protection

Supports gut lining and tissue-protective mechanisms.

Recovery integration

Works best with rehab, mobility, nutrition, and sleep strategy.

Clinical benefits

Why IPS considers BPC-157 Injectable.

Benefits depend on patient goals, health history, protocol design, adherence, and response.

Tendon & ligament supportSupports connective-tissue recovery goals.
Muscle and soft tissueSupports soft-tissue repair and recovery capacity.
Joint-related recoverySupports collagen, perfusion, and inflammatory-balance pathways.
SoftWave integrationFits broader IPS recovery plans that include SoftWave Therapy.

Process

How this works at IPS.

01

Consultation

Review goals, symptoms, medical history, medications, and current care.

02

Candidacy Review

Review contraindications, route, tolerance considerations, and clinical fit.

03

Custom Protocol

If appropriate, IPS reviews instructions, expectations, and follow-up timing.

04

Ongoing Care

Follow-ups evaluate tolerance, response, and next-step adjustments.

Questions

Frequently asked.

How is BPC-157 administered?

When appropriate, IPS uses provider-guided subcutaneous protocols with storage, handling, site rotation, and monitoring instructions.

How is injectable BPC different from oral BPC?

Injectable BPC is more targeted for tendon, ligament, muscle, joint, wound, or localized soft-tissue goals. Oral BPC is more gut-focused.

Can it be combined with TB-500?

Yes. IPS uses BPC-157 + TB-500 as a foundation recovery blend when broader systemic support is appropriate.

Is KPV standalone?

No. KPV is only included as a component inside the advanced recovery blend.

Contact

Discuss BPC-157 Injectable with IPS.

Complete the form and IPS will follow up about consultation scheduling and next steps.

Send your details and IPS can follow up about consultation scheduling, eligibility, and next steps.

Medical noteThis educational page is not a diagnosis or treatment plan. Consultation and provider review are required.

Clinical sourcing note: IPS does not operate as a gray-market peptide source. Protocols are reviewed through a medical model with patient screening, candidacy review, provider oversight, and pharmacy-sourced products when prescribed. Peptides are not positioned as research-use-only products or self-directed online ordering.